SCHEMBL20614482

SCHEMBL20614482

CC(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(C)=O)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPA1 P15085 1/20 0.43
CPA2 P48052 1/20 0.43
CPA4 Q9UI42 1/20 0.43
GNPAT O15228 1/20 0.41
FOLH1 Q04609 4/20 0.41
NAALAD2 Q9Y3Q0 2/20 0.41
RIMKLA Q8IXN7 1/20 0.41
SIRT5 Q9NXA8 1/20 0.40
ALDH1A1 P00352 1/20 0.40
BMP1 P13497 2/20 0.39
BACE1 P56817 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
ALOX15 P16050 1/20 0.37
NFKB1 P19838 1/20 0.37
PTGS2 P35354 1/20 0.37
THPO P40225 1/20 0.37
RECQL P46063 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29695567 0.89 GNPAT (0.47) CPA1CPA2CPA4GNPATFOLH1
SCHEMBL24333569 0.87 FOLH1 (0.41) FOLH1NAALAD2RIMKLABMP1DPP4
SCHEMBL7166591 0.86 GNPAT (0.48) GNPATSIRT5BMP1BACE1
SCHEMBL7729169 0.85 SIRT5 (0.42) CPA1CPA2CPA4GNPATFOLH1
SCHEMBL17424544 0.83 BACE1 (0.46) CPA1CPA2CPA4GNPATFOLH1
SCHEMBL20747363 0.83 CPA1 (0.46) CPA1CPA2CPA4GNPATFOLH1
SCHEMBL6534663 0.83 GNPAT (0.54) GNPATBMP1BACE1
SCHEMBL19492628 0.83 BMP1 (0.40) BMP1BACE1
SCHEMBL13043586 0.82 LMNA (0.35) CPA1CPA2CPA4ALDH1A1BACE1
SCHEMBL22310788 0.82 GNPAT (0.47) GNPATBMP1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11746126-B2 Bicyclic peptide ligands with detectable moieties and uses thereof Bicyclerd Limited (GB) 2023-09-05 US disclosed
US-20210079045-A1 BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE MOIETIES AND USES THEREOF Bicyclerd Limited (GB) 2021-03-18 US disclosed
WO-2019002842-A1 BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE MOIETIES AND USES THEREOF Bicyclerd Limited (GB) 2019-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11746126-B2 Bicyclic peptide ligands with detectable moieties and uses thereof VIP, NGLY1, GRPR CPA1 403/4885CPA2 447/4885CPA4 127/4885
US-20210079045-A1 BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE MOIETIES AND USES THEREOF VIP, NGLY1, GRPR CPA1 403/4885CPA2 447/4885CPA4 127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.